Models
SAKAR HEALTHCARE LIMITEDSAKARPharmaceuticals & Biotechnology
₹569per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model₹569implied FY26 P/E 35.1× · EV/EBITDA 19.2×
Against CMP ₹1,000.50−43.1%close of 8 Oct 2026
Growth the CMP implies—%no growth rate between −20% and 45% a year brings the value to the CMP on your other inputs
Value after FY3175%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.
Where the methods land · ₹ per share · the dashed line is the CMP
DCF, rate ±1 · growth ±1your model across the sensitivity grid
₹437₹834
52-week rangetraded range, a fact not a value
₹346₹1,230
From enterprise to equity · ₹ crore
| PV of FY27–FY31 free cash flow | 328 |
| PV of terminal value | 994 |
| Enterprise value | 1,322 |
| less net debt | (55) |
| less non-controlling interest | 0 |
| add non-operating investments | 0 |
| Equity value | 1,267 |
| ÷ 2.23 crore shares | ₹569 |
75% of the value sits after FY31. Usual when return on capital sits near the cost of capital; the 5 explicit years carry little of it.
Free cash flow, filed and modelled · ₹ '000 crore
Filed, cash from operations − capexModelled free cash flow to firm
Sensitivity · ₹ per share
Down Across| WACC ↓terminal growth → | 4.0% | 4.5% | 5.0% | 5.5% | 6.0% |
|---|---|---|---|---|---|
| 10.00% | 589 | 633 | 687 | 752 | 834 |
| 10.50% | 542 | 579 | 623 | 675 | 739 |
| 11.00% | 502 | 533 | 569 | 612 | 664 |
| 11.50% | 467 | 494 | 524 | 560 | 602 |
| 12.00% | 437 | 459 | 485 | 516 | 551 |
The outlined cell is your model. Green figures sit above the CMP of ₹1,000.50; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.
Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together
| 10th · 50th · 90th percentile, ₹ per share | 405 · 560 · 778 |
| Draws below the CMP | 99% |
| Rank correlation with revenue growth | +0.69 |
| Rank correlation with ebitda margin | +0.57 |
| Rank correlation with discount rate | −0.36 |
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.
Projected cash flow to the firm · ₹ crore
History Forward| ₹ crore | FY23 | FY24 | FY25 | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 133 | 153 | 178 | 252 | 327 | 425 | 553 | 719 | 935 |
| growth % | 4.0 | 15.0 | 15.8 | 41.8 | 30.0 | 30.0 | 30.0 | 30.0 | 30.0 |
| EBITDA | 33 | 38 | 50 | 69 | 90 | 117 | 152 | 197 | 256 |
| margin % | 24.8 | 25.0 | 27.9 | 27.4 | 27.4 | 27.4 | 27.4 | 27.4 | 27.4 |
| less depreciation | (15) | (18) | (21) | (24) | (31) | (40) | (52) | (68) | (88) |
| EBIT | 18 | 20 | 29 | 45 | 59 | 77 | 100 | 129 | 168 |
| less tax on EBIT | (11) | (14) | (18) | (23) | (30) | (39) | |||
| NOPAT | 35 | 45 | 59 | 76 | 99 | 129 | |||
| add depreciation | 15 | 18 | 21 | 24 | 31 | 40 | 52 | 68 | 88 |
| less capex | (82) | (60) | (32) | 0 | 0 | (12) | (31) | (61) | (105) |
| less working-capital build | — | (6) | (7) | (9) | (12) | (16) | |||
| Free cash flow to firm | (49) | (35) | 3 | — | 70 | 80 | 88 | 94 | 96 |
| Discount factor | 0.949 | 0.855 | 0.770 | 0.694 | 0.625 | ||||
| Present value | 67 | 68 | 68 | 65 | 60 |
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.
The three statements, projected · ₹ crore · debt held at 55, dividends at 0% of profit
| ₹ crore | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| EBIT | 45 | 59 | 77 | 100 | 129 | 168 |
| Interest at 12.1% on debt | (7) | (7) | (7) | (7) | (7) | |
| Profit before tax | 52 | 70 | 93 | 123 | 162 | |
| Profit after tax | 30 | 40 | 54 | 71 | 94 | 124 |
| Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance sheet, year end | ||||||
| Cash | 0 | 65 | 140 | 222 | 311 | 402 |
| Working capital | 18 | 24 | 31 | 40 | 53 | 68 |
| Net block and other assets | 462 | 432 | 404 | 383 | 376 | 394 |
| Debt | 55 | 55 | 55 | 55 | 55 | 55 |
| Equity | 324 | 365 | 418 | 489 | 583 | 707 |
| Balance check | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow | ||||||
| From operations | 65 | 86 | 114 | 150 | 196 | |
| Investing (capex) | 0 | (12) | (31) | (61) | (105) | |
| Financing (dividends) | 0 | 0 | 0 | 0 | 0 | |
| Net change in cash | 65 | 74 | 83 | 89 | 91 | |
| Free cash flow to equity | 65 | 74 | 83 | 89 | 91 | |
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.
Scenarios side by side · ₹ per share
| Scenario | Template | Growth | Margin | Rate | Terminal | ₹ / share | vs CMP |
|---|---|---|---|---|---|---|---|
| Base · editing | DCF | 30% | 27.4% | 11.00% | 5% | ₹569 | (43.1)% |
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.